<![CDATA[NOVO — Oktober 2022]]>Novos pillehåb skuffer analytikere https://www.proinvestor.com/investornyt/885636/novos-pillehab-skuffer-analytikere

]]>https://dev.proinvestor.com/forum/topic/400290/novo-oktober-2022RSS for NodeSat, 06 Jun 2026 22:18:00 GMTMon, 03 Oct 2022 05:48:24 GMT60<![CDATA[Reply to NOVO — Oktober 2022 on Mon, 31 Oct 2022 05:44:24 GMT]]>Danske aktier: Regnskabssæsonen kulminerer - Investorerne holder øje med Netcompany, ISS, Vestas, APM og Novo Nordisk https://www.proinvestor.com/boards/107403

]]>https://dev.proinvestor.com/forum/post/7978289https://dev.proinvestor.com/forum/post/7978289Mon, 31 Oct 2022 05:44:24 GMT<![CDATA[Reply to NOVO — Oktober 2022 on Fri, 28 Oct 2022 06:49:09 GMT]]>Spændende at høre om hvad Novo melder ud om Wegovy/Catalent på onsdag.

]]>https://dev.proinvestor.com/forum/post/7978284https://dev.proinvestor.com/forum/post/7978284Fri, 28 Oct 2022 06:49:09 GMT<![CDATA[Reply to NOVO — Oktober 2022 on Tue, 18 Oct 2022 03:57:58 GMT]]>Shortpositioner - Danske aktier https://www.proinvestor.com/boards/107056

]]>https://dev.proinvestor.com/forum/post/7978292https://dev.proinvestor.com/forum/post/7978292Tue, 18 Oct 2022 03:57:58 GMT<![CDATA[Reply to NOVO — Oktober 2022 on Tue, 18 Oct 2022 03:52:36 GMT]]>Roche solgte mindre end ventet - Novo-konkurrentprodukt skuffer https://www.proinvestor.com/investornyt/891555/roche-solgte-mindre-end-ventet-novo-konkurrentprodukt-skuffer

]]>https://dev.proinvestor.com/forum/post/7978285https://dev.proinvestor.com/forum/post/7978285Tue, 18 Oct 2022 03:52:36 GMT<![CDATA[Reply to NOVO — Oktober 2022 on Fri, 14 Oct 2022 02:11:14 GMT]]>Test

]]>https://dev.proinvestor.com/forum/post/7978288https://dev.proinvestor.com/forum/post/7978288Fri, 14 Oct 2022 02:11:14 GMT<![CDATA[Reply to NOVO — Oktober 2022 on Thu, 06 Oct 2022 08:52:01 GMT]]>t amerikanske medicinalselskab Eli Lilly har fået såkaldt fast track-status til lægemiddelkandidaten Tirzepatid i behandling af fedme i USA.

]]>https://dev.proinvestor.com/forum/post/7978291https://dev.proinvestor.com/forum/post/7978291Thu, 06 Oct 2022 08:52:01 GMT<![CDATA[Reply to NOVO — Oktober 2022 on Wed, 05 Oct 2022 08:22:44 GMT]]>Aktier/middag: Defensive aktier i plus med Genmab og Novo i toppen https://www.proinvestor.com/investornyt/886625/aktier-middag-defensive-aktier-i-plus-med-genmab-og-novo-i-toppen

]]>https://dev.proinvestor.com/forum/post/7978287https://dev.proinvestor.com/forum/post/7978287Wed, 05 Oct 2022 08:22:44 GMT<![CDATA[Reply to NOVO — Oktober 2022 on Tue, 04 Oct 2022 09:33:14 GMT]]>Novo/Sydbank: Nyt ugentligt insulin kan blive blockbuster https://www.proinvestor.com/investornyt/886154/novo-sydbank-nyt-ugentligt-insulin-kan-blive-blockbuster

]]>https://dev.proinvestor.com/forum/post/7978286https://dev.proinvestor.com/forum/post/7978286Tue, 04 Oct 2022 09:33:14 GMT<![CDATA[Reply to NOVO — Oktober 2022 on Mon, 03 Oct 2022 10:45:52 GMT]]>Novo når endemål med fase 3-forsøg med ugentlig insulin https://www.proinvestor.com/investornyt/885733/novo-nar-endemal-med-fase-3-forsog-med-ugentlig-insulin

]]>https://dev.proinvestor.com/forum/post/7978290https://dev.proinvestor.com/forum/post/7978290Mon, 03 Oct 2022 10:45:52 GMT